Preparing existing and new products for distribution in international markets is a major challenge, with significant differences between regions and countries. This affects product information and clinical documentation translations, a critical component of getting life sciences products approved for licence and distribution in individual markets. Underestimating or cutting corners on this could lead to errors that delay market access, a product recall, or even a threat to patient safety.